Thomas Schwenger Sells 10,000 Shares of Veeva Systems (NYSE:VEEV) Stock

Veeva Systems Inc. (NYSE:VEEV) insider Thomas Schwenger sold 10,000 shares of Veeva Systems stock in a transaction on Thursday, August 27th. The shares were sold at an average price of $281.33, for a total value of $2,813,300.00. Following the completion of the sale, the insider directly owned 19,449 shares of the company’s stock, valued at approximately $5,471,587.17. This represents a 33.96% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Veeva Systems Trading Down 2.2%

Veeva Systems stock opened at $279.34 on Wednesday. The stock has a fifty day moving average price of $213.52 and a 200 day moving average price of $185.80. Veeva Systems Inc. has a 52 week low of $148.05 and a 52 week high of $310.50. The firm has a market capitalization of $45.38 billion, a P/E ratio of 45.94, a PEG ratio of 1.22 and a beta of 0.97.

Veeva Systems (NYSE:VEEV) last issued its quarterly earnings results on Wednesday, August 26th. The technology company reported $2.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.23 by $0.12. Veeva Systems had a return on equity of 14.25% and a net margin of 29.34%.The firm had revenue of $927.96 million for the quarter, compared to analyst estimates of $905.38 million. During the same period last year, the company earned $1.99 EPS. The firm’s quarterly revenue was up 17.6% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. As a group, equities analysts predict that Veeva Systems Inc. will post 6.7 EPS for the current year.

Hedge Funds Weigh In On Veeva Systems

Institutional investors and hedge funds have recently bought and sold shares of the stock. California State Teachers Retirement System raised its stake in shares of Veeva Systems by 16,590.3% during the second quarter. California State Teachers Retirement System now owns 39,388,224 shares of the technology company’s stock valued at $6,990,228,000 after purchasing an additional 39,152,230 shares during the period. Norges Bank purchased a new position in shares of Veeva Systems in the fourth quarter valued at $332,412,000. Durable Capital Partners LP purchased a new position in shares of Veeva Systems in the second quarter valued at $281,351,000. Fundsmith LLP acquired a new stake in Veeva Systems during the 2nd quarter valued at $144,955,000. Finally, Arrowstreet Capital Limited Partnership grew its holdings in Veeva Systems by 203.0% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 913,281 shares of the technology company’s stock valued at $160,427,000 after purchasing an additional 611,868 shares in the last quarter. Hedge funds and other institutional investors own 88.20% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on VEEV shares. Royal Bank Of Canada increased their price target on shares of Veeva Systems from $275.00 to $325.00 and gave the stock an “outperform” rating in a research note on Thursday, August 27th. BNP Paribas Exane reiterated an “outperform” rating and issued a $285.00 target price on shares of Veeva Systems in a report on Thursday, June 4th. Raymond James Financial restated an “outperform” rating and set a $225.00 price target on shares of Veeva Systems in a research note on Thursday, June 4th. Morgan Stanley lifted their price objective on Veeva Systems from $215.00 to $275.00 and gave the company an “equal weight” rating in a research note on Thursday, August 27th. Finally, Zacks Research downgraded shares of Veeva Systems from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 14th. Nineteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Veeva Systems has a consensus rating of “Moderate Buy” and a consensus price target of $284.46.

More Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva announced Veeva Falcon Safety, an agentic safety-operations product designed to automate adverse-event intake, case processing, and follow-up across all E2B-compliant safety systems and intake channels. The offering could reduce costs, accelerate workflows, and strengthen compliance for biopharmaceutical customers. Veeva Falcon Safety announcement
• Positive Sentiment: Recent results remain a support for the stock: Veeva reported quarterly revenue of approximately $928 million, up 17.6% year over year, and EPS of $2.35 versus the $2.23 consensus estimate. Management’s call highlighted accelerating Vault CRM adoption and sustained growth. Veeva Q2 2027 earnings call transcript
• Neutral Sentiment: Michael Burry trimmed his Veeva position after the stock nearly doubled, reportedly following a trade-management rule to take profits. The move may attract attention, but it appears to reflect portfolio management rather than a specific deterioration in Veeva’s business outlook. Michael Burry trims Veeva position
• Negative Sentiment: Insider Thomas Schwenger sold 10,000 shares for approximately $2.8 million, reducing his direct stake by about 34%. Because the sale was conducted under a pre-arranged Rule 10b5-1 plan, it is a relatively limited bearish signal, but it can still weigh on sentiment following Veeva’s sharp rally. Veeva insider sale
• Negative Sentiment: With Veeva trading near its 12-month high and at roughly 46 times earnings, investors may be locking in gains and demanding continued strong execution. Profit-taking by prominent investors and the insider sale provide near-term selling pressure despite the company’s favorable growth profile.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.